Breast Fibromatosis: Clinical and Pathological Insights From Two Case Reports Authors: Vahid Soleimani, Behnaz Jahanbin, Aysan Nozheh Published: 2026 ABSTRACT ABSTRACTBreast fibromatosis is a benign, locally aggressive spindle‐cell tumor mimicking carcinoma. We report two cases in patients aged 15 and 61 years, highlighting its wide age range. Accurate histopathology prevents overtreatment. Modern management emphasizes individualized care, including active surveillance, complete surgical excision when needed, and long‐term follow‐up. Introduction Desmoid tumor is an uncommon tumor with a variable spectrum of activities ranging from a local lesion to an aggressive and destructive one. The term is derived from the Greek term “desmos,” which means band or tendon‐like structure [1]. The incidence is approximately 0.2% of all neoplasms of the breast and 0.3% of all solid neoplasms [2]. The etiology of mammary fibromatosis is unknown, and breast imaging examinations are not specific for fibromatosis; distinguishing mammary fibromatosis from malignant breast tumors through physical examination and imaging techniques can be difficult. Advanced imaging modalities, including PET/CT, have increasingly been utilized in the evaluation of tumor response and surveillance, though their role in benign fibromatosis remains limited [3]. There appears to be general agreement that a complete wide excision is the treatment of choice for fibromatosis involving only the breast [4, 5, 6, 7]. However, contemporary management of desmoid tumors has evolved significantly, with active surveillance now recommended as an initial approach for many patients, particularly those with asymptomatic or slowly progressive disease [8, 9]. In this article, we report two cases of breast fibromatosis affecting patients of different age groups. Case History/Examination Case 1 A 15‐year‐old female presented with a palpable lump in her right breast for 5 months. There was no family history of breast and ovarian cancer. Her past medical history was not significant. She reported the onset of menarche at age 9 and a negative birth history. During the physical examination, a hard, non‐tender lump with ill‐defined margins in the upper inner quadrant of the right breast was found. There was no nipple retraction, discharge, or skin change. The initial breast ultrasound showed a 32 × 17 mm suspicious lobulated hypoechogenic lesion at the 1 o'clock position in the near zone of the right breast (BIRADS = 3) (Figure 1). The second breast ultrasound 2 months later showed a 63 × 36 mm oval well‐defined heteroechoic lesion in the upper inner quadrant of the right breast (BIRADS = 4a), with no significant axillary node noted. The lesion, in comparison with the previous ultrasound study, increased in size by about twofold. Core needle biopsy performed at another institution revealed breast fibromatosis with myofibroblastic differentiation. Case 1: Breast ultrasound: A 32 × 17 mm lobulated, hypoechogenic lesion at the 1 o'clock position in the near zone of the right breast, classified as BIRADS 3. Timeline Clarification The timeline of events and tumor size measurements require careful interpretation. The initial ultrasound (month 0) measured 32 × 17 mm. At month 2, ultrasound showed enlargement to 63 × 36 mm. The surgical resection (month 3) yielded a gross specimen measuring 11 × 8 × 5 cm, which represents the entire excised tissue block including surrounding breast parenchyma, not the tumor itself. The actual tumor size within this specimen was approximately 7 × 5 × 4 cm, consistent with the ultrasound findings and expected growth pattern. This clarification addresses the apparent size discrepancy, as imaging measurements reflect the lesion while gross specimen measurements include adjacent tissue. Case 2 A 61‐year‐old woman with no significant past medical history and no family history of breast cancer presented with a palpable mass in the upper outer quadrant of the left breast, which she had noticed 3 months prior. Initial breast sonography revealed a solid hypoechoic mass with irregular borders measuring 29 × 26 × 15.5 mm at the 2–3 o'clock position (mid zone) of the left breast (BIRADS = 5) (Figure 2). Core needle biopsy at another medical center rendered a diagnosis of low‐grade spindle cell neoplasm. Given the imaging characteristics suspicious for malignancy (BIRADS 5) and the non‐definitive biopsy result, the patient underwent modified radical mastectomy after multidisciplinary discussion. Intraoperatively, frozen section analysis of margins was performed, and axillary lymph node dissection was not performed given the benign nature of the final diagnosis, consistent with the non‐metastasizing behavior of fibromatosis. In retrospect, an excisional biopsy or repeat core biopsy with a comprehensive immunohistochemical panel would have been preferable to avoid the more extensive surgery; however, the clinical presentation and imaging findings at the time raised sufficient concern for malignancy to warrant the procedure performed. Case 2: Breast ultrasound: A solid hypoechoic mass with irregular borders measuring 29 × 26 × 15.5 mm at position 2–3 o'clock (mid zone) of the left breast, classified as BIRADS 5. (Image quality is limited as it was captured from printed material; original DICOM images were unavailable at the time of publication.) Differential Diagnosis Metaplastic (spindle cell) carcinoma, low‐grade fibrosarcoma/spindle cell sarcoma, nodular fasciitis, reactive fibroblastic lesions, phyllodes tumor. Results (Outcome and Follow‐Up) Case 1 The patient underwent core needle biopsy in another medical center, which revealed breast fibromatosis with myofibroblastic differentiation. The patient underwent local excision of the lesion with clear margins in our medical center 1 month later, and gross description showed a circumscribed mass measuring 11 × 8 × 5 cm (the entire excised specimen, with the tumor itself measuring approximately 7 × 5 × 4 cm), with a white‐gray whorled cut surface (Figure 3). Case 1: Gross appearance: The excised surgical specimen measuring 11 × 8 × 5 cm (entire tissue block) with a firm, white‐gray whorled cut surface. The actual tumor measured approximately 7 × 5 × 4 cm. Histopathological examination of the tumor showed poorly demarcated, spindle‐shaped myofibroblasts arranged in long sweeping fascicles (Figure 4). There was little mitotic activity. Immunohistochemical findings of the mass showed a positive reaction with SMA, a focally positive reaction with beta‐catenin, Ki67 about 2%, and a negative reaction for CD34, P63, SOX10, CKAE1/AE3 (Pan CK), and CK5/6 (Figure 5A–H). Histopathology and IHC results confirmed desmoid‐type fibromatosis. Case 1: Histological sections of the lesion stained with hematoxylin and eosin (H&E); poorly demarcated proliferation of spindle‐shaped myofibroblasts arranged in long, sweeping fascicles—characteristic histologic pattern of breast fibromatosis. (A–H) Case 1: Immunohistochemical (IHC) staining of the tumor cells. (A) Diffuse positivity for SMA. (B) Focal nuclear staining for beta‐catenin. (C) Negative for CD34. (D) Negative for p63. (E) Negative for CK5,6. (F) Negative for Pan CK. (G) Negative for P63. (H) Negative for Sox10. These findings are consistent with breast fibromatosis. [Scale bars: 500 μm]. At the 2‐month follow‐up, the patient developed a new palpable mass in her right breast. Imaging revealed a lesion in the surgical bed, which was suspected to represent either recurrent fibromatosis or residual disease. The rapidity of this presentation suggests that the “recurrence” may more accurately represent residual microscopic disease or local progression rather than true de novo recurrence, particularly given the close proximity to the initial surgical site. The patient underwent a right partial mastectomy. The surgically removed specimen was 8 × 5 × 3 cm in size, containing a grossly irregular, firm tumor measuring 2.5 × 2.4 × 2 cm with off‐white whorled patterns without necrosis. Final histopathology was reported as recurrent fibromatosis (Figure 6). The tumor invasion of the underlying tissue involved resected muscles. There were negative margins, with the closest margin being less than 0.1 cm from the deep aspect. The patient is currently 2 months out from surgery with no issues. The rapid recurrence in this case highlights the aggressive local behavior that can occur in some desmoid tumors, particularly in younger patients, and underscores the importance of close surveillance. Case 1: Histological sections of the recurrent lesion stained with hematoxylin and eosin (H&E) at magnification ×100: The recurrent lesion shows poorly demarcated, spindle‐shaped myofibroblasts arranged in long sweeping fascicles, consistent with recurrent breast fibromatosis. Case 2 The patient subsequently underwent core needle biopsy at another medical center, where the diagnosis of low‐grade spindle cell neoplasm was rendered. One month later, she was referred to our institution and underwent left modified radical mastectomy. It is important to note that, in retrospect, given the benign nature of fibromatosis, breast‐conserving surgery with negative margins would have been the preferred approach, consistent with current management guidelines. However, the initial BIRADS 5 classification and non‐definitive biopsy necessitated definitive surgical management at that time. Gross examination of the mastectomy specimen revealed a unifocal, cream‐white, firm tumor measuring 3 × 3 × 2 cm with a whorled cut surface, located in all four quadrants with irregular borders described as “ropes thrown in different ways.” The tumor was situated 1.5 cm from the deep margin and 1 cm from the superficial margin (Figure 7). Axillary lymph nodes were not dissected, consistent with the non‐metastasizing nature of fibromatosis. Case 2: Gross inspection of the mastectomy specimen demonstrated a solitary, firm, cream‐white tumor measuring 3 × 3 × 2 cm, exhibiting a whorled appearance on cut section. Histopathological evaluation revealed a poorly circumscribed proliferation of spindle‐shaped cells organized in long, sweeping fascicles (Figure 8A–C). Immunohistochemical studies showed a negative reaction for CKAE1/AE3 (Pan CK), CK5/6, 34βE12, p63, CD34, and SMA patchy positive in spindle cells, S100 rarely positive in spindle cells, and Beta‐catenin was positive in spindle cells, and the Ki‐67 proliferation index was 2%–3% in spindle cells (Figure 9A,B). Histopathology and IHC results confirmed fibromatosis. (A–C) Case 2: Histological sections stained with hematoxylin and eosin (H&E). (A) ×40 magnification, (B) ×100 magnification, and (C) ×400 magnification show poorly demarcated proliferation of spindle‐shaped cells arranged in long, sweeping fascicles—characteristic histologic pattern of breast fibromatosis. (A, B) Case 2: Immunohistochemistry (IHC) staining (×400 magnification). (A) Beta‐catenin positive in spindle cells. (B) Ki‐67 proliferation index was 2%–3% in spindle cells. (Negative reactions for CKAE1/AE3 (Pan CK), CK5/6, 34βE12, p63, CD34 are not shown in this figure). [Scale bars: 20 μm]. The patient was discharged in good condition following surgery and has had no reported recurrence to date at the time of this report. Discussion A desmoid tumor can occur anywhere in the body. However, its etiology is still unknown. Physical, hormonal, and genetic factors play important roles in the development of desmoid tumors [10]. Mammary desmoid‐type fibromatosis is a rare and locally aggressive intermediate tumor of the breast; it originates from fibroblasts and myofibroblasts within the breast parenchyma and does not metastasize [4, 5, 6, 7]. Patients range in age from 13 to 83 years old. The reported mean age at diagnosis ranges from 37 to 50.3 years [11, 12]. Most commonly, it is found in one breast; however, both breasts may be affected [2]. The etiology of this lesion remains a subject of debate. Trauma, particularly surgical trauma, has been emphasized as an etiological factor. The occurrence of extramammary fibromatosis in younger women, often during pregnancy, the rapid tumor growth in women of childbearing age compared to juvenile and postmenopausal women and men, and spontaneous regression at menopause have suggested the influence of sex steroid hormones in the growth of this tumor [13, 14, 15, 16, 17, 18]. In our case, fibromatosis affected only one breast. Moreover, the patient did not have any history of genetic factors or breast surgery. Clinically, breast fibromatosis almost always presents with a painless, solitary, firm or hard tumor that suggests carcinoma on clinical examination. Rarely, the tumor is non‐palpable and detected initially by mammography [19]. Skin dimpling and retraction are relatively common signs of breast fibromatosis and are caused by fibrous tissue contraction vs. desmoplastic reaction, which is similar to tethering and is associated with malignancy [20]. On mammography, breast fibromatosis often appears as an irregularly shaped, noncalcified, high‐density mass with speculated margins [21]. On ultrasound, fibromatosis appears as an irregular, hypoechoic mass with no associated adenopathy [22, 23]. In our case, the tumor was also firm, not tender, with echoscopically seen well‐defined margins. Magnetic resonance imaging (MRI) is the best radiological diagnostic method for diagnosing desmoid tumors [24]. On MRI images, a desmoid tumor may look as ill‐defined hypointense or isointense masses on T1‐weighted images or hyperintense masses on T2‐weighted images [2]. On gross pathology, these lesions are usually poorly circumscribed, firm, and gray or white in color [11]. Histopathologically, these lesions may have heterogeneous growth patterns and do not exhibit calcification. Often, the lesion, composed of spindle cells, appears moderately cellular, with some collagen deposition and a low mitotic rate (1 mitotic figure per 10 high‐power fields [HPF]). Nuclear atypia and pleomorphism are unlikely to be seen [25]. Immunohistochemical staining for β‐catenin with nuclear positivity is also useful in establishing a diagnosis, but there are no specific immunomarkers for breast fibromatosis [4, 26]. Another major concern about mammary fibromatosis is the exclusion of the diagnosis of metaplastic carcinoma, because spindle cell tumors with a myoepithelial immunophenotype may be diagnosed as metaplastic carcinoma even with weak or absent cytokeratin expression. In the present report, both epithelial (AE1/AE3) and myoepithelial markers (p63) were negative [27, 28]. Modern Management of Desmoid Tumors The management of desmoid tumors has evolved considerably over the past decade. Historically, aggressive surgical resection with wide margins was considered the standard of care. However, contemporary approaches recognize that the natural history of desmoid tumors is highly variable, with some tumors remaining stable or even regressing spontaneously. This understanding has led to a paradigm shift toward more individualized, risk‐adapted management strategies [8, 9]. Active Surveillance Current consensus guidelines recommend active surveillance as the initial management strategy for most patients with sporadic desmoid tumors, particularly those with asymptomatic or minimally symptomatic disease and tumors in non‐critical locations [8]. This approach involves regular clinical and imaging follow‐up to monitor for disease progression, with intervention reserved for cases demonstrating significant growth or causing symptoms. The rationale for this approach is to avoid unnecessary surgical morbidity, as many desmoid tumors will remain stable or regress without intervention. Surgical Management When intervention is required, surgical excision with negative margins remains an important treatment option. However, the emphasis has shifted from “wide local excision” to “function‐sparing resection,” recognizing that the morbidity of extensive surgery may outweigh the benefits, particularly given the high recurrence rates even with negative margins. For breast fibromatosis, breast‐conserving surgery is preferred when feasible, with modified radical mastectomy reserved for extensive disease or when breast conservation is not technically possible. Axillary lymph node dissection is not indicated due to the absence of metastatic potential. Systemic Therapy For patients with progressive or symptomatic disease who are not candidates for surgery, systemic therapies have shown efficacy. These include non‐steroidal anti‐inflammatory drugs (NSAIDs), hormonal agents (such as tamoxifen), tyrosine kinase inhibitors (imatinib, sorafenib), and cytotoxic chemotherapy. The choice of therapy depends on tumor location, growth rate, symptoms, and patient preferences [8, 9]. Radiotherapy Radiation therapy may be considered for unresectable or recurrent disease, though its use has decreased with the advent of effective systemic therapies. The role of adjuvant radiotherapy after resection of positive margins remains controversial, with some guidelines recommending observation rather than routine adjuvant radiation [4, 8, 9]. The importance of multidisciplinary management cannot be overstated. Patients with desmoid tumors should be evaluated by a team including surgeons, medical oncologists, radiation oncologists, and pathologists to develop an individualized treatment plan that balances the risks and benefits of each approach. This principle applies equally to the management of breast fibromatosis, where the goal is to achieve local control while preserving breast cosmesis and function [29]. In Case 1, the rapid “recurrence” within 2 months of initial surgery with reported clear margins warrants careful consideration. This may represent either: (1) true recurrence, (2) residual microscopic disease that was not identified on initial pathological examination, or (3) multifocal disease. The rapidity of recurrence suggests that complete eradication of the tumor may not have been achieved despite negative margins, possibly due to the infiltrative nature of the lesion or the presence of satellite microscopic foci. This case underscores the importance of close postoperative surveillance and the need for clear communication with patients regarding the risk of local recurrence, even after apparently complete excision. In Case 2, the performance of a modified radical mastectomy for a 3 cm lesion highlights the diagnostic challenges posed by this entity. With the benefit of hindsight, a less extensive procedure would have been preferable. This case emphasizes the importance of obtaining definitive preoperative diagnosis through core needle biopsy with comprehensive immunohistochemical staining and the value of multidisciplinary discussion before proceeding with radical surgery. The treatment of tumors and tumor‐like lesions has increasingly emphasized individualized therapy according to disease biology, local aggressiveness, and anticipated morbidity [29]. This paradigm shift from one‐size‐fits‐all approaches to personalized medicine reflects the broader evolution of cancer treatment over the past several decades, moving from primarily cytotoxic strategies toward more targeted and biologically rational interventions [30]. This approach is particularly relevant for desmoid tumors, where the clinical course is unpredictable and the potential for treatment‐related harm must be carefully weighed against the benefits of intervention. Future research should focus on identifying molecular and clinical predictors of disease behavior to further refine patient selection for active surveillance versus intervention. In conclusion, desmoid‐type fibromatosis of the breast is an uncommon, benign, locally aggressive fibroblastic tumor with a lack of metastatic potential; it may present with features of malignancy on physical examination and imaging. Modern management emphasizes an individualized approach, with active surveillance for many patients, function‐sparing surgical resection when intervention is indicated, and systemic therapies for progressive disease. Given the high tendency to recur, early diagnosis and close long‐term follow‐up remain essential. Author Contributions Aysan Nozheh: investigation, data curation, formal analysis, writing – review and editing, writing – original draft, validation. Behnaz Jahanbin: investigation, resources, validation, writing – review and editing. Vahid Soleimani: conceptualization, methodology, project administration, supervision, writing – original draft. Funding The authors have nothing to report. Ethics Statement The study was conducted in accordance with the ethical principles of the Declaration of Helsinki, and ethical approval was obtained from the ethics committee of Tehran University of Medical Sciences. Consent Written informed consent was obtained from both patients for publication of this case report and any accompanying images. Conflicts of Interest We declare that we have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Also, we declare that we are preparing articles in our personal capacity.